BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 12884292)

  • 1. Oxidative-stress-induced T lymphocyte hyporesponsiveness is caused by structural modification rather than proteasomal degradation of crucial TCR signaling molecules.
    Cemerski S; van Meerwijk JP; Romagnoli P
    Eur J Immunol; 2003 Aug; 33(8):2178-85. PubMed ID: 12884292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased ubiquitination and reduced expression of LCK in T lymphocytes from patients with systemic lupus erythematosus.
    Jury EC; Kabouridis PS; Abba A; Mageed RA; Isenberg DA
    Arthritis Rheum; 2003 May; 48(5):1343-54. PubMed ID: 12746907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential development of structural and functional alterations in T cells from tumor-bearing mice.
    Correa MR; Ochoa AC; Ghosh P; Mizoguchi H; Harvey L; Longo DL
    J Immunol; 1997 Jun; 158(11):5292-6. PubMed ID: 9164948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequestration of CD4-associated Lck from the TCR complex may elicit T cell hyporesponsiveness in nonobese diabetic mice.
    Zhang J; Salojin K; Delovitch TL
    J Immunol; 1998 Feb; 160(3):1148-57. PubMed ID: 9570528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TCR subunit specificity of CTLA-4-mediated signaling.
    Siu E; Carreno BM; Madrenas J
    J Leukoc Biol; 2003 Dec; 74(6):1102-7. PubMed ID: 12972512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signal transduction abnormalities in T lymphocytes from patients with advanced renal carcinoma: clinical relevance and effects of cytokine therapy.
    Bukowski RM; Rayman P; Uzzo R; Bloom T; Sandstrom K; Peereboom D; Olencki T; Budd GT; McLain D; Elson P; Novick A; Finke JH
    Clin Cancer Res; 1998 Oct; 4(10):2337-47. PubMed ID: 9796963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of p56(lck) tyrosine kinase by isothiazolones.
    Trevillyan JM; Chiou XG; Ballaron SJ; Tang QM; Buko A; Sheets MP; Smith ML; Putman CB; Wiedeman P; Tu N; Madar D; Smith HT; Gubbins EJ; Warrior UP; Chen YW; Mollison KW; Faltynek CR; Djurić SW
    Arch Biochem Biophys; 1999 Apr; 364(1):19-29. PubMed ID: 10087161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and activity of signaling molecules in T lymphocytes obtained from patients with metastatic melanoma before and after interleukin 2 therapy.
    Rabinowich H; Banks M; Reichert TE; Logan TF; Kirkwood JM; Whiteside TL
    Clin Cancer Res; 1996 Aug; 2(8):1263-74. PubMed ID: 9816296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in expression and function of signal-transducing proteins in tumor-associated T and natural killer cells in patients with ovarian carcinoma.
    Lai P; Rabinowich H; Crowley-Nowick PA; Bell MC; Mantovani G; Whiteside TL
    Clin Cancer Res; 1996 Jan; 2(1):161-73. PubMed ID: 9816103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reconstitution of deficient T cell receptor zeta chain restores T cell signaling and augments T cell receptor/CD3-induced interleukin-2 production in patients with systemic lupus erythematosus.
    Nambiar MP; Fisher CU; Warke VG; Krishnan S; Mitchell JP; Delaney N; Tsokos GC
    Arthritis Rheum; 2003 Jul; 48(7):1948-55. PubMed ID: 12847689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recruitment of Sprouty1 to immune synapse regulates T cell receptor signaling.
    Lee JS; Lee JE; Oh YM; Park JB; Choi H; Choi CY; Kim IH; Lee SH; Choi K
    J Immunol; 2009 Dec; 183(11):7178-86. PubMed ID: 19915061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD3ζ-chain expression of human T lymphocytes is regulated by TNF via Src-like adaptor protein-dependent proteasomal degradation.
    Érsek B; Molnár V; Balogh A; Matkó J; Cope AP; Buzás EI; Falus A; Nagy G
    J Immunol; 2012 Aug; 189(4):1602-10. PubMed ID: 22798681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular Phospho-Flow cytometry reveals novel insights into TCR proximal signaling events. A comparison with Western blot.
    Haas A; Weckbecker G; Welzenbach K
    Cytometry A; 2008 Sep; 73(9):799-807. PubMed ID: 18548611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effects of rosmarinic acid on Lck SH2 domain binding to a synthetic phosphopeptide.
    Ahn SC; Oh WK; Kim BY; Kang DO; Kim MS; Heo GY; Ahn JS
    Planta Med; 2003 Jul; 69(7):642-6. PubMed ID: 12898421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic recruitment of the adaptor protein LAT: LAT exists in two distinct intracellular pools and controls its own recruitment.
    Bonello G; Blanchard N; Montoya MC; Aguado E; Langlet C; He HT; Nunez-Cruz S; Malissen M; Sanchez-Madrid F; Olive D; Hivroz C; Collette Y
    J Cell Sci; 2004 Mar; 117(Pt 7):1009-16. PubMed ID: 14996932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged exposure of T cells to TNF down-regulates TCR zeta and expression of the TCR/CD3 complex at the cell surface.
    Isomäki P; Panesar M; Annenkov A; Clark JM; Foxwell BM; Chernajovsky Y; Cope AP
    J Immunol; 2001 May; 166(9):5495-507. PubMed ID: 11313388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of methyl-beta-cyclodextrin on T lymphocytes lipid rafts with aging.
    Larbi A; Douziech N; Khalil A; Dupuis G; Gheraïri S; Guérard KP; Fülöp T
    Exp Gerontol; 2004 Apr; 39(4):551-8. PubMed ID: 15050290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fc epsilonRI gamma can support T cell development and function in mice lacking endogenous TCR zeta-chain.
    Shores E; Flamand V; Tran T; Grinberg A; Kinet JP; Love PE
    J Immunol; 1997 Jul; 159(1):222-30. PubMed ID: 9200458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in T cell receptor and signal transduction molecules in melanoma patients.
    Zea AH; Curti BD; Longo DL; Alvord WG; Strobl SL; Mizoguchi H; Creekmore SP; O'Shea JJ; Powers GC; Urba WJ
    Clin Cancer Res; 1995 Nov; 1(11):1327-35. PubMed ID: 9815928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissecting the molecular mechanisms of TCR zeta chain downregulation and T cell signaling abnormalities in human systemic lupus erythematosus.
    Nambiar MP; Juang YT; Krishnan S; Tsokos GC
    Int Rev Immunol; 2004; 23(3-4):245-63. PubMed ID: 15204087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.